Company news

Neuropace, Inc. news in 2026

Neuropace, Inc.'s news releases, calls and decks from 2026, newest first.

View company

NeuroPace to Report Third Quarter 2026 Financial Results on November 12, 2026

October 29, 2026

NeuroPace to Participate in 2026 Cantor Global Healthcare Conference

September 1, 2026

NeuroPace to Participate in Wells Fargo 21st Annual Healthcare Conference

August 31, 2026

NeuroPace Reports Second Quarter 2026 Financial Results and Raises 2026 Revenue Guidance

August 11, 2026

NeuroPace Receives FDA Guidance on PMA Supplement for Indication Expansion into Idiopathic Generalized Epilepsy

July 27, 2026

NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting

May 29, 2026

NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care

May 29, 2026

NeuroPace Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Guidance

May 12, 2026

NeuroPace to Report First Quarter 2026 Financial Results on May 12, 2026

April 29, 2026

NeuroPace Highlights Expanding Clinical Evidence Leadership with Published 3-Year Post-Approval Study (PAS) Results in Neurology and NAUTILUS Presentation at AAN 2026

April 27, 2026

NeuroPace to Present at the 25th Annual Needham Virtual Healthcare Conference

April 10, 2026

NeuroPace to Present at the Leerink Global Healthcare Conference

March 4, 2026

NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook

March 3, 2026

NeuroPace to Report Fourth Quarter 2025 Financial Results on March 3, 2026

February 20, 2026

NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

January 13, 2026

Calls in 2026

Decks in 2026